Vitalsource Technologies, Inc. Defining Optimal Immunotherapies For Type 1 Diabetes: | DealShopping USA
  1. Home
  2. Vitalsource Technologies, Inc. Defining Optimal Immunotherapies For Type 1 Diabetes: Novartis Foundati
  • #

Vitalsource Technologies, Inc. Defining Optimal Immunotherapies For Type 1 Diabetes: Novartis Foundati

170.00 USD

Share:

Related products

Vitalsource Technologies, Inc. The Innovative Company: An Ill-defined Object

Vitalsource Technologies, Inc. The Innovative Company: An Ill-defined Object

142.00 USD
Vitalsource Technologies, Inc. Software Defined Radio

Vitalsource Technologies, Inc. Software Defined Radio

175.00 USD
Vitalsource Technologies, Inc. Software Defined Radio

Vitalsource Technologies, Inc. Software Defined Radio

144.00 USD
Vitalsource Technologies, Inc. VMware Software-Defined Storage: A Design Guide to the Policy-Driven, Software-Defined Storage Era

Vitalsource Technologies, Inc. VMware Software-Defined Storage: A Design Guide to the Policy-Driven, Software-Defined Storage Era

36.00 USD
Vitalsource Technologies, Inc. Software Defined Radio

Vitalsource Technologies, Inc. Software Defined Radio

171.00 USD
Vitalsource Technologies, Inc. Guidelines For Defining Process Safety Competency Requirements

Vitalsource Technologies, Inc. Guidelines For Defining Process Safety Competency Requirements

81.00 USD